Stock listing
Frankfurt:6JH0 IN8bio, Inc. Aktie
German listing (Frankfurt) of IN8bio, Inc. · home listing NASDAQ:INAB
Follow IN8bio, Inc. into a list and get an email when it puts out news.
Share price · FWB:6JH0
€0.745 EUR +0.015 (+2.1%)
Close on Nov 16, 2026
- Day range
- €0.730 – €0.745 EURNov 16, 2026
- Market cap
- €7.34M EURAt the close on Nov 16, 2026 · price × 9.86M shares outstanding
- 52-week range
- €0.727 – €2.116 EURLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
- Traded on an average day
- €248 EURMedian day 0 shares · 55 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:INAB · Home | $0.816 USD | -0.004 (-0.5%) | 5,046,184 | $0.832 | $0.934 | $0.724 | $0.820 | Close on Nov 16, 2026 |
| Frankfurt:6JH0 | €0.745 EUR | +0.015 (+2.1%) | — | €0.730 | €0.745 | €0.730 | €0.730 | Close on Nov 16, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 6, 2026 · FWB:6JH0 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.727 | -0.093 | -11.3% | €0.729 | €0.729 | €0.727 | 0 | |
| €0.820 | -0.028 | -3.3% | €0.820 | €0.821 | €0.816 | 0 | |
| €0.848 | +0.038 | +4.7% | €0.832 | €0.857 | €0.823 | 0 | |
| €0.810 | +0.016 | +2.0% | €0.792 | €0.818 | €0.788 | 0 | |
| €0.794 | -0.056 | -6.6% | €0.794 | €0.797 | €0.793 | 0 | |
| €0.850 | -0.018 | -2.1% | €0.850 | €0.858 | €0.846 | 3,000 | |
| €0.868 | -0.007 | -0.8% | €0.859 | €0.869 | €0.841 | 0 | |
| €0.875 | +0.066 | +8.2% | €0.834 | €0.877 | €0.833 | 0 | |
| €0.809 | -0.053 | -6.1% | €0.809 | €0.809 | €0.809 | 0 | |
| €0.862 | +0.009 | +1.1% | €0.894 | €0.912 | €0.861 | 322 | |
| €0.853 | -0.095 | -10.0% | €0.858 | €0.864 | €0.853 | 0 | |
| €0.948 | -0.058 | -5.8% | €0.950 | €0.954 | €0.936 | 0 | |
| €1.006 | +0.057 | +6.0% | €1.006 | €1.006 | €1.006 | 0 | |
| €0.949 | -0.021 | -2.2% | €0.949 | €0.949 | €0.949 | 0 | |
| €0.970 | -0.071 | -6.8% | €0.971 | €0.973 | €0.964 | 0 | |
| €1.041 | -0.023 | -2.2% | €1.041 | €1.041 | €1.041 | 0 | |
| €1.064 | +0.010 | +0.9% | €1.064 | €1.064 | €1.064 | 0 | |
| €1.054 | -0.049 | -4.4% | €1.050 | €1.054 | €1.043 | 0 | |
| €1.103 | -0.082 | -6.9% | €1.101 | €1.110 | €1.095 | 0 | |
| €1.185 | -0.004 | -0.3% | €1.185 | €1.185 | €1.185 | 0 | |
| €1.189 | -0.030 | -2.5% | €1.203 | €1.211 | €1.179 | 0 | |
| €1.219 | +0.021 | +1.8% | €1.223 | €1.225 | €1.219 | 500 | |
| €1.198 | -0.051 | -4.1% | €1.215 | €1.220 | €1.194 | 0 | |
| €1.249 | +0.049 | +4.1% | €1.249 | €1.249 | €1.249 | 0 | |
| €1.200 | -0.036 | -2.9% | €1.224 | €1.241 | €1.190 | 0 | |
| €1.236 | +0.075 | +6.5% | €1.241 | €1.248 | €1.236 | 0 | |
| €1.161 | +0.049 | +4.4% | €1.152 | €1.165 | €1.146 | 0 | |
| €1.112 | +0.040 | +3.7% | €1.131 | €1.132 | €1.111 | 0 | |
| €1.072 | +0.051 | +5.0% | €1.076 | €1.077 | €1.072 | 0 | |
| €1.021 | +0.052 | +5.4% | €1.019 | €1.022 | €1.018 | 0 | |
| €0.969 | +0.039 | +4.2% | €0.974 | €0.988 | €0.969 | 0 | |
| €0.930 | -0.034 | -3.5% | €0.935 | €0.943 | €0.928 | 0 | |
| €0.964 | +0.058 | +6.4% | €0.964 | €0.964 | €0.964 | 0 | |
| €0.906 | -0.005 | -0.5% | €0.898 | €0.909 | €0.892 | 0 | |
| €0.911 | +0.006 | +0.7% | €0.911 | €0.911 | €0.911 | 0 | |
| €0.905 | +0.068 | +8.1% | €0.915 | €0.927 | €0.903 | 12,600 | |
| €0.837 | -0.048 | -5.4% | €0.854 | €0.854 | €0.825 | 0 | |
| €0.885 | -0.045 | -4.8% | €0.885 | €0.885 | €0.885 | 0 | |
| €0.930 | +0.021 | +2.3% | €0.930 | €0.930 | €0.930 | 0 | |
| €0.909 | -0.037 | -3.9% | €0.903 | €0.915 | €0.902 | 0 | |
| €0.946 | +0.036 | +4.0% | €0.921 | €0.946 | €0.921 | 0 | |
| €0.910 | -0.030 | -3.2% | €0.911 | €0.912 | €0.910 | 0 | |
| €0.940 | -0.061 | -6.1% | €0.941 | €0.942 | €0.940 | 0 | |
| €1.001 | -0.001 | -0.1% | €0.996 | €1.007 | €0.992 | 0 | |
| €1.002 | +0.037 | +3.8% | €1.002 | €1.002 | €1.002 | 0 | |
| €0.965 | +0.041 | +4.4% | €0.965 | €0.965 | €0.965 | 0 | |
| €0.924 | +0.011 | +1.2% | €0.924 | €0.924 | €0.924 | 0 | |
| €0.913 | +0.003 | +0.3% | €0.913 | €0.913 | €0.913 | 0 | |
| €0.910 | +0.099 | +12.2% | €0.913 | €0.920 | €0.907 | 0 | |
| €0.811 | -0.065 | -7.4% | €0.859 | €0.859 | €0.798 | 0 | |
| €0.876 | -0.117 | -11.8% | €0.874 | €0.877 | €0.873 | 0 | |
| €0.993 | +0.014 | +1.4% | €0.993 | €0.993 | €0.990 | 0 | |
| €0.979 | +0.064 | +7.0% | €0.979 | €0.979 | €0.979 | 0 | |
| €0.915 | -0.167 | -15.4% | €0.977 | €0.984 | €0.910 | 0 | |
| €1.082 | +0.071 | +7.0% | €1.063 | €1.082 | €1.059 | 0 | |
| €1.011 | +0.013 | +1.3% | €1.004 | €1.019 | €1.002 | 40 | |
| €0.998 | +0.046 | +4.8% | €1.003 | €1.005 | €0.998 | 0 | |
| €0.952 | +0.019 | +2.0% | €0.952 | €0.952 | €0.949 | 0 | |
| €0.933 | +0.075 | +8.7% | €0.933 | €0.933 | €0.933 | 0 | |
| €0.858 | -0.132 | -13.3% | €0.913 | €0.921 | €0.858 | 0 |
Splits
1 split · FWB:6JH0 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-30 | Consolidation |
- Ticker
- Frankfurt:6JH0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Calls
Replays
IN8bio (NASDAQ:INAB) Q1 2022 Earnings Call
Tue, May 17, 2022 · 6:00 PM ET
Watch Transcript
Latest news
IN8bio Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Nov 5, 2026
Closed €0.727 (-11.3%) on Nov 6, 2026
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep 10, 2026
Closed €0.91 (-3.2%) on Sep 10, 2026
IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development
Sep 9, 2026
Closed €0.94 (-6.1%) on Sep 9, 2026
IN8bio Reports Inducement Grant under Nasdaq Listing Rule 5635(4)
Aug 11, 2026
Closed €0.817 (-0.7%) on Aug 11, 2026
IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 6, 2026
Closed €0.82 (+0.9%) on Aug 7, 2026
IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
Jul 9, 2026
Closed €1.22 (+4.2%) on Jul 9, 2026
IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies
Jun 3, 2026
Closed €1.27 (-13.2%) on Jun 3, 2026
IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026
Jun 1, 2026
Closed €1.49 (+4.1%) on Jun 1, 2026
Financings
Private placement of common stock and pre-funded warrants
Dec 19, 2025
Announced: up to US$40.2M · US$1.38 a share · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Buyers: Coastlands Capital; Stonepine Capital Management; 683 Capital Partners, LP
Insiders: Directors and officers of the Company are participating.
Use of proceeds: IND enabling studies of INB-619, submitting INB-200 and INB-400 glioblastoma data to the FDA, working capital and general corporate purposes
Decks
Investor Presentation (2024)
Investor deck · 56 slides · 2024
IN8bio, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 21 in the last 12 months · 119 in all · newest Nov 16, 2026 · oldest 2021
- Calls
- 1 call with a replay · 1 with a transcript · latest May 17, 2022
- Decks
- 1 deck · latest 2024
Where IN8bio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:INAB · Home listing | NASDAQ | United States | USD |
| LS Exchange:A4197Y | LS Exchange | Germany | EUR |
| BOATS:INAB | BOATS | United States | USD |
| gettex:6JH0 | gettex | Germany | EUR |
| Lang & Schwarz:A4197Y | Lang & Schwarz | Germany | EUR |
| Dusseldorf:6JH0 | Dusseldorf | Germany | EUR |
| Frankfurt:6JH0 · This page | Frankfurt | Germany | EUR |
| Munich:6JH0 | Munich | Germany | EUR |
| Stuttgart:6JH0 | Stuttgart | Germany | EUR |
| Tradegate:6JH0 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about IN8bio, Inc.